These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8935178)

  • 1. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
    Coleman MD; Tingle MD; Park BK
    J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats.
    Malfará WR; Pereira CP; Santos AC; Queiroz RH
    Pharmacol Res; 2002 Apr; 45(4):269-73. PubMed ID: 12030789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dapsone-induced methaemoglobinaemia].
    Rytter D; Mrgan M
    Ugeskr Laeger; 2013 Nov; 175(46):2799-800. PubMed ID: 24629319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine and dapsone-mediated methaemoglobinaemia.
    Mehta M
    Anaesthesia; 2007 Nov; 62(11):1188. PubMed ID: 17924910
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion.
    Craig D; Cadden IS; Gormley WP; Riley MS; Jones FG; McMullin MF
    Int J Clin Pract; 2000 Apr; 54(3):194-6. PubMed ID: 10829363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone toxicity: some current perspectives.
    Coleman MD
    Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
    Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
    Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late recovery of dapsone-induced methemoglobinemia.
    Wieringa A; Bethlehem C; Hoogendoorn M; van der Maten J; van Roon EN
    Clin Toxicol (Phila); 2014 Jan; 52(1):80-1. PubMed ID: 24308869
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic rebound methaemoglobinaemia after treatment with dapsone.
    Jonkers BRP; Cobanoglu G; Blok EJ; Köbben JJ; van der Helm MW; van Hoof IJAM; Tintu AN; Bethlehem C; Versmissen J
    Neth J Med; 2020 Sep; 78(5):277-281. PubMed ID: 33093248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.
    Coleman MD
    Br J Dermatol; 1993 Nov; 129(5):507-13. PubMed ID: 8251346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factitious methemoglobinemia.
    Carr KM; Elias L; Caruana LC; Rabinowitz I
    Am J Hematol; 1999 Nov; 62(3):196-7. PubMed ID: 10539888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.
    Mitchell MC; Schenker S; Speeg KV
    J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia.
    Mayo W; Leighton K; Robertson B; Ruedy J
    Can J Anaesth; 1987 Jan; 34(1):79-82. PubMed ID: 3829290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.